High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Circulation - United States
doi 10.1161/circulationaha.113.006286
Full Text
Open PDFAbstract
Available in full text
Date
February 11, 2014
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)